Upon C5aR antagonist administration, the tumor growth in A549-vec cell-bearing mice was significantly impaired, and the tumor volume was equal to that of tumors derived from A549-shTF cells (Figure 5A). This evidence concerns the gene C5AR1 and neoplasm.